IN A comprehensive update to pharmaceutical benefits regulation, the Department of Health and Aged Care has announced amendments to key instruments governing the listing and funding of pharmaceutical benefits in Australia, which took effect from this week.
A notable change is the removal of the requirement for patient signatures upon receipt of pharmaceutical benefits in pharmacies.
Moreover, the procedure for authorising increases to the maximum quantity of repeats of prescriptions has been revised and is now a more straightforward process.
The Prescriber Bag Determination has also been updated to ensure more judicious management of stock.
These regulatory updates mark a progressive step in streamlining services.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Apr 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Apr 24